Yun Fu1, Zhigang Zhuang2, Michelle Dewing3, Sophia Apple4, Helena Chang3. 1. Department of Surgery, Revlon/UCLA Breast Center, David Geffen School of Medicine, University of California of Los Angeles Los Angeles, United States ; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine Shanghai, China. 2. Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine Shanghai, China. 3. Department of Surgery, Revlon/UCLA Breast Center, David Geffen School of Medicine, University of California of Los Angeles Los Angeles, United States. 4. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA Los Angeles, CA, United States.
Abstract
BACKGROUND: In recent years, radical breast cancer surgery has been largely replaced by breast conservation treatment, due to early diagnosis and more effective adjuvant treatment. While breast conservation is mostly preferred, the trend of bilateral mastectomy has risen in the United States. The aim of this study is to determine factors influencing patients' choice for having contralateral prophylactic mastectomy (CPM). METHODS: This is a retrospective study of 373 patients diagnosed with primary invasive breast cancer who were treated by bilateral or unilateral mastectomy (BM or UM) at the Revlon/UCLA Breast Center between Jan. 2002 and Dec. 2010. In the BM group, only those with unilateral breast cancer who chose CPM were included in the analysis. RESULTS: When compared with the UM group, the following factors were found to be associated with BM: younger age, pre-menopausal, a family history of breast/ovarian cancer, BRCA mutation, more breast biopsies, history of breast augmentation, having MRI study within 6 months before the surgery, more likely to have reconstruction and sentinel lymph node biopsy (SLNB) and fewer had neoadjuvant/adjuvant chemotherapy/radiation. When patients with bilateral breast cancer were excluded, multivariate logistic regression analysis indicated younger patients with negative nodes, SLNB as the only nodal surgery and positive family history were significant factors predicting CPM and immediate reconstruction using tissue expanders or implants. CONCLUSION: Younger age, lower TN stage, requiring only SLNB and high risk family history predict contralateral prophylactic mastectomy. Tissue expander/implant-based reconstructions were more frequently chosen by patients with BM.
BACKGROUND: In recent years, radical breast cancer surgery has been largely replaced by breast conservation treatment, due to early diagnosis and more effective adjuvant treatment. While breast conservation is mostly preferred, the trend of bilateral mastectomy has risen in the United States. The aim of this study is to determine factors influencing patients' choice for having contralateral prophylactic mastectomy (CPM). METHODS: This is a retrospective study of 373 patients diagnosed with primary invasive breast cancer who were treated by bilateral or unilateral mastectomy (BM or UM) at the Revlon/UCLA Breast Center between Jan. 2002 and Dec. 2010. In the BM group, only those with unilateral breast cancer who chose CPM were included in the analysis. RESULTS: When compared with the UM group, the following factors were found to be associated with BM: younger age, pre-menopausal, a family history of breast/ovarian cancer, BRCA mutation, more breast biopsies, history of breast augmentation, having MRI study within 6 months before the surgery, more likely to have reconstruction and sentinel lymph node biopsy (SLNB) and fewer had neoadjuvant/adjuvant chemotherapy/radiation. When patients with bilateral breast cancer were excluded, multivariate logistic regression analysis indicated younger patients with negative nodes, SLNB as the only nodal surgery and positive family history were significant factors predicting CPM and immediate reconstruction using tissue expanders or implants. CONCLUSION: Younger age, lower TN stage, requiring only SLNB and high risk family history predict contralateral prophylactic mastectomy. Tissue expander/implant-based reconstructions were more frequently chosen by patients with BM.
Authors: Anthony E Dragun; Jianmin Pan; Elizabeth C Riley; Barbara Kruse; Mary R Wilson; Shesh Rai; Dharamvir Jain Journal: Am J Clin Oncol Date: 2013-08 Impact factor: 2.339
Authors: Ellen Warner; Kimberley Hill; Petrina Causer; Donald Plewes; Roberta Jong; Martin Yaffe; William D Foulkes; Parviz Ghadirian; Henry Lynch; Fergus Couch; John Wong; Frances Wright; Ping Sun; Steven A Narod Journal: J Clin Oncol Date: 2011-03-28 Impact factor: 44.544
Authors: Elizabeth B Habermann; Andrea Abbott; Helen M Parsons; Beth A Virnig; Waddah B Al-Refaie; Todd M Tuttle Journal: J Clin Oncol Date: 2010-06-14 Impact factor: 44.544
Authors: Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith Journal: J Clin Oncol Date: 2014-02-18 Impact factor: 44.544
Authors: Rajini Katipamula; Amy C Degnim; Tanya Hoskin; Judy C Boughey; Charles Loprinzi; Clive S Grant; Kathleen R Brandt; Sandhya Pruthi; Christopher G Chute; Janet E Olson; Fergus J Couch; James N Ingle; Matthew P Goetz Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: Amanda K Arrington; Stephanie L Jarosek; Beth A Virnig; Elizabeth B Habermann; Todd M Tuttle Journal: Ann Surg Oncol Date: 2009-08-04 Impact factor: 5.344
Authors: Jonathan L Vandergrift; Joyce C Niland; Richard L Theriault; Stephen B Edge; Yu-Ning Wong; Loretta S Loftus; Tara M Breslin; Clifford A Hudis; Sara H Javid; Hope S Rugo; Samuel M Silver; Eva M Lepisto; Jane C Weeks Journal: J Natl Cancer Inst Date: 2012-12-21 Impact factor: 13.506
Authors: Rebecca Nash; Michael Goodman; Chun Chieh Lin; Rachel A Freedman; Laura S Dominici; Kevin Ward; Ahmedin Jemal Journal: JAMA Surg Date: 2017-07-01 Impact factor: 14.766
Authors: Patricia A Parker; Susan K Peterson; Yu Shen; Isabelle Bedrosian; Dalliah M Black; Alastair M Thompson; Jonathan C Nelson; Sarah M DeSnyder; Robert L Cook; Kelly K Hunt; Robert J Volk; Scott B Cantor; Wenli Dong; Abenaa M Brewster Journal: J Clin Oncol Date: 2018-07-25 Impact factor: 44.544
Authors: Christopher D Lopez; Rachel Bluebond-Langner; Carrie A Houssock; Sheri S Slezak; Emily Bellavance Journal: Front Oncol Date: 2019-01-09 Impact factor: 6.244